| Execution period | 5 years |
|---|
BSE filing, NSE: INDOBORAX. Summary written from the filing by ALFA Finder's alert engine.
Indo Borax & Chemicals Ltd: key numbers
- Share price
- ₹406.90
- Market cap
- ₹1,306 Cr
- Revenue (annual)
- ₹215.4 Cr
- Net profit (annual)
- ₹50.27 Cr
- P/E (TTM)
- 23.2×Sector 34.1×
- Promoter holding
- 38.41%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Borax & Chemicals Ltd
All →Indo Borax & Chemicals Order Update
Indo Borax & Chemicals amended its Share Purchase Agreement dated August 20, 2026, by removing lock-in restrictions and the right of first refusal. This amendment clarifies promoter status.
Indo Borax & Chemicals Other Announcement
Indo Borax & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax created a pledge over 14% of subsidiary Kronox's shares to secure a ₹225 crore term loan. The pledge does not alter the company's control of the subsidiary.
- Value
- ₹225.0 Cr
Indo Borax & Chemicals Annual General Meeting
Indo Borax & Chemicals Ltd issued a notice of postal ballot to seek shareholder approval for creating security on borrowings up to Rs. 400 Crore. Voting will occur via remote e-voting.
Indo Borax & Chemicals Acquisition Worth ₹246.1 Cr
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited for ₹246.12 Crore.
- Value
- ₹246.1 Cr
Indo Borax & Chemicals Acquisition
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited. The transaction involved purchasing 2,38,44,000 equity shares via a share purchase agreement.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.